QS Investors’s Edwards Lifesciences EW Stock Holding History

QS Investors’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	$2.31M	Buy	22,309 +1,148	+5%	+$108K	0.03%	335
2021 Q1	$1.77M	Buy	21,161 +2,600	+14%	+$220K	0.02%	379
2020 Q4	$1.69M	Sell	18,561 -67,443	-78%	-$5.59M	0.02%	373
2020 Q3	$6.87M	Sell	86,004 -13,642	-14%	-$1.06M	0.09%	165
2020 Q2	$6.89M	Sell	99,646 -7,910	-7%	-$562K	0.1%	173
2020 Q1	$6.76M	Sell	107,556 -1,200	-1%	-$86.5K	0.11%	158
2019 Q4	$8.43M	Buy	108,756 +4,368	+4%	+$341K	0.08%	179
2019 Q3	$7.65M	Buy	104,388 +2,412	+2%	+$169K	0.08%	179
2019 Q2	$6.28M	Buy	101,976 +1,050	+1%	+$63.5K	0.07%	212
2019 Q1	$6.44M	Sell	100,926 -57,450	-36%	-$3.28M	0.07%	189
2018 Q4	$8.09M	Sell	158,376 -34,785	-18%	-$1.76M	0.1%	132
2018 Q3	$11.2M	Buy	193,161 +8,370	+5%	+$409K	0.11%	128
2018 Q2	$8.97M	Sell	184,791 -3,753	-2%	-$175K	0.09%	151
2018 Q1	$8.77M	Sell	188,544 -36,732	-16%	-$1.6M	0.09%	145
2017 Q4	$8.46M	Sell	225,276 -10,419	-4%	-$382K	0.08%	161
2017 Q3	$8.59M	Sell	235,695 -16,668	-7%	-$636K	0.07%	173
2017 Q2	$9.95M	Sell	252,363 -1,503	-0.6%	-$54.9K	0.08%	144
2017 Q1	$7.96M	Sell	253,866 -104,823	-29%	-$3.28M	0.07%	176
2016 Q4	$11.2M	Sell	358,689 -570	-0.2%	-$18.5K	0.09%	168
2016 Q3	$14.4M	Sell	359,259 -72,117	-17%	-$2.72M	0.11%	144
2016 Q2	$14.3M	Sell	431,376 -11,451	-3%	-$392K	0.12%	148
2016 Q1	$13M	Buy	442,827 +267	+0.1%	+$7.37K	0.12%	153
2015 Q4	$11.7M	Sell	442,560 -1,008	-0.2%	-$26.2K	0.11%	165
2015 Q3	$10.5M	Sell	443,568 -58,866	-12%	-$1.42M	0.11%	175
2015 Q2	$11.9M	Sell	502,434 -778,416	-61%	-$17.6M	0.15%	160
2015 Q1	$30.4M	Buy	1,280,850 +511,872	+67%	+$11.5M	0.34%	60
2014 Q4	$16.3M	Buy	768,978 +382,380	+99%	+$7.68M	0.19%	130
2014 Q3	$6.58M	Buy	386,598 +365,520	+1,734%	+$5.77M	0.18%	127
2014 Q2	$302K	Buy	+21,078	New	+$286K	0.01%	526
2013 Q3	–	Sell	-21,000	Closed	-$235K	–	610
2013 Q2	$235K	Buy	+21,000	New	+$249K	0.01%	610

Other funds holding EW

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

QS Investors's EW Position: Q2 2021 in Review

QS Investors increased its Edwards Lifesciences (EW) stake by 5.4% in Q2 2021, buying an estimated $108K and bringing the position to 22,309 shares worth $2.31M. The position accounts for 0.03% of the portfolio, ranked #335.

QS Investors first reported a position in EW in Q2 2013 and has held it in 30 quarters since. The position peaked at $30.4M in Q1 2015. 1,185 funds tracked by Wall St. Rank hold EW as of Q2 2021.

QS Investors held 22,309 shares of Edwards Lifesciences worth $2.31M as of Q2 2021.
QS Investors bought 1,148 Edwards Lifesciences shares in Q2 2021, an estimated $108K.
Edwards Lifesciences made up 0.03% of QS Investors's portfolio in Q2 2021, its #335 holding.
QS Investors first reported a position in Edwards Lifesciences in Q2 2013 and has held it in 30 quarters since.
QS Investors's Edwards Lifesciences position peaked at $30.4M in Q1 2015.
1,185 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2021.

Based on QS Investors's 13F filing for Q2 2021, filed 13 Aug 2021.